Hemoptysis in the CF Community — Paul K. Mohabir, MD, FACP, MPH (Video)

While highly effective CFTR modulators have transformed the landscape of cystic fibrosis (CF) care, hemoptysis continues to affect many people with CF. In this podcast, Paul K. Mohabir, MD, FACP, MPH explains what hemoptysis is, examines its underlying causes, and discusses the current standard of care for managing significant bleeding, including bronchial artery embolization. Drawing on historical and current research, Dr. Mohabir also explores what is known, and what remains to be learned, about hemoptysis in the post-modulator era, underscoring the need for ongoing research to improve outcomes for people with CF. Click here to donate to CFRI and support the cystic fibrosis community worldwide: https://cfri.app.neoncrm.com/forms/donation Your thoughts are valuable to us and will help with future podcast planning! Respond to our short survey https://www.surveymonkey.com/r/56NJC95, and you’ll be entered in our quarterly drawing for a $25 Etsy gift card. Winners notified by email. Funding for this CF Community Voices podcast has been provided to date by Viatris and Vertex Pharmaceuticals.